These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9869224)

  • 21. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
    Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
    Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
    Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix.
    Chaney AW; Eifel PJ; Logsdon MD; Morris M; Wharton JT
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):113-8. PubMed ID: 10477014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Locally advanced carcinoma of the cervix uteri (stage IIB-IIIB TNM-UICC): radiotherapy combined with simultaneous daily low-dose platinum. Phase II study].
    Micheletti E; La Face B; Bianchi E; Cagna E; Sartori E
    Radiol Med; 1996 May; 91(5):628-34. PubMed ID: 8693131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma.
    Houvenaeghel G; Lelievre L; Gonzague-Casabianca L; Buttarelli M; Moutardier V; Goncalves A; Resbeut M
    Gynecol Oncol; 2006 Feb; 100(2):338-43. PubMed ID: 16213008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
    Haie-Meder C; Fervers B; Chauvergne J; Fondrinier E; Lhommé C; Guastalla JP; Resbeut M
    Bull Cancer; 1999 Oct; 86(10):829-41. PubMed ID: 10572234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis.
    Yoon HI; Cha J; Keum KC; Lee HY; Nam EJ; Kim SW; Kim S; Kim YT; Kim GE; Kim YB
    Radiat Oncol; 2015 Jan; 10():18. PubMed ID: 25582425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128.
    Gaffney DK; Winter K; Dicker AP; Miller B; Eifel PJ; Ryu J; Avizonis V; Fromm M; Greven K
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):104-9. PubMed ID: 17084549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group.
    DiSilvestro PA; Walker JL; Morrison A; Rose PG; Homesley H; Warshal D;
    Gynecol Oncol; 2006 Dec; 103(3):1038-42. PubMed ID: 16889823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Phase I Evaluation of Extended Field Radiation Therapy With Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women With Cervical Carcinoma Metastatic to the Para-aortic Lymph Nodes: An NRG Oncology/Gynecologic Oncology Group Study.
    Boardman CH; Brady WE; Dizon DS; Kunos CA; Moore KN; Zanotti KM; Matthews C; Cosin JA; Aghajanian C; Fracasso PM
    Gynecol Oncol; 2018 Nov; 151(2):202-207. PubMed ID: 30174176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of pelvic tumor control and impact on survival in carcinoma of the uterine cervix treated with radiation therapy alone.
    Perez CA; Kuske RR; Camel HM; Galakatos AE; Hederman MA; Kao MS; Walz BJ
    Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):613-21. PubMed ID: 3350717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced radiosensitization with interferon-alpha-2b and cisplatin in the treatment of locally advanced cervical carcinoma.
    Stock RG; Dottino P; Jennings TS; Terk M; DeWyngaert JK; Beddoe AM; Cohen C
    Gynecol Oncol; 1997 Dec; 67(3):309-15. PubMed ID: 9441780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent 5-fluorouracil, daily low-dose cisplatin, and radiotherapy in stage IIIB cervical cancer. A phase II prospective study.
    Hsu WL; Shueng PW; Jen YM; Wu CJ; Liu HS; Su CC; Hwang JM
    Am J Clin Oncol; 1996 Jun; 19(3):263-7. PubMed ID: 8638538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radical surgery +/- intraoperative electron beam radiotherapy in locally advanced cervical cancer.
    Jurado M; Martínez-Monge R; García-Foncillas J; Azinovic I; Aristu J; López-García G; Brugarolas A
    Gynecol Oncol; 1999 Jul; 74(1):30-7. PubMed ID: 10385548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A.
    Sundfør K; Tropé CG; Högberg T; Onsrud M; Koern J; Simonsen E; Bertelsen K; Westberg R
    Cancer; 1996 Jun; 77(11):2371-8. PubMed ID: 8635109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial.
    Stehman FB; Ali S; Keys HM; Muderspach LI; Chafe WE; Gallup DG; Walker JL; Gersell D
    Am J Obstet Gynecol; 2007 Nov; 197(5):503.e1-6. PubMed ID: 17980189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.